Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-20IMA3Form 3 Filing for ImageneBio, Inc. by Robert B LallyMEDIUM
This filing is an initial report of beneficial ownership on Form 3 for Robert B Lally, the Principal Accounting Officer of ImageneBio, Inc. The filing was delayed due to administrative reasons in obtaining EDGAR filing credentials. It reports direct ownership of 58,778 shares of Common Stock, including 56,940 restricte...
Micro CapBiotechnology
2026-04-20INDP3Form 3 Filing for Indaptus Therapeutics, Inc. - Initial Statement of Beneficial Ownership
This filing is an initial statement of beneficial ownership (Form 3) for Indaptus Therapeutics, Inc. (INDP). The reporting owner is Lu Qinglai, identified by CIK 0002127285, who is a director at the company. The address provided is C/O Indaptus Therapeutics, Inc., 3 Columbus Circle, 15th Floor, New York, NY 10019. The ...
Nano CapBiotechnology
2026-04-20ImageneBio, Inc.3Form 3 Filing for ImageneBio, Inc. by Robert B LallyDuplicateMEDIUM
This filing is an initial report of beneficial ownership on Form 3 for Robert B Lally, the Principal Accounting Officer of ImageneBio, Inc. The filing was delayed due to administrative reasons in obtaining EDGAR filing credentials. It reports direct ownership of 58,778 shares of Common Stock, including 56,940 restricte...
Micro CapBiotechnology
2026-04-20Indaptus Therapeutics, Inc.3Form 3 Filing for Indaptus Therapeutics, Inc. - Initial Statement of Beneficial OwnershipDuplicate
This filing is an initial statement of beneficial ownership (Form 3) for Indaptus Therapeutics, Inc. (INDP). The reporting owner is Lu Qinglai, identified by CIK 0002127285, who is a director at the company. The address provided is C/O Indaptus Therapeutics, Inc., 3 Columbus Circle, 15th Floor, New York, NY 10019. The ...
Nano CapBiotechnology
2026-04-20NGNE3Christina Shafer Power of Attorney Filing for Neurogene Inc.
This SEC Form 3 filing documents a power of attorney granted by Christina Shafer, Chief Commercial Officer of Neurogene Inc. (NGNE), to several individuals including Rachel McMinn, Christine Mikail, Donna M. Cochener, Ryan A. Murr, and Branden C. Berns. The power of attorney authorizes these individuals to prepare and ...
Small CapBiotechnology